2009
DOI: 10.1016/j.bmc.2008.11.021
|View full text |Cite
|
Sign up to set email alerts
|

Search for new pharmacophores for antimalarial activity. Part I: Synthesis and antimalarial activity of new 2-methyl-6-ureido-4-quinolinamides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 43 publications
(10 citation statements)
references
References 24 publications
0
10
0
Order By: Relevance
“…A mixture of 3 (218.21 mg, 1 m m ) and 3‐fluoroaniline ( 4a , 1 m m ) was heated and stirred at reflux in acetic acid (10 mL) for 1 h. The yellow precipitate that formed was filtered hot, washed with hot acetic acid, diethyl ether, and dried to give the desired nitroquinazoline 5a as light yellow solid (180 mg, rate 63.2%). m.p: 230.7–232.6 °C (227–229 °C, lit …”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…A mixture of 3 (218.21 mg, 1 m m ) and 3‐fluoroaniline ( 4a , 1 m m ) was heated and stirred at reflux in acetic acid (10 mL) for 1 h. The yellow precipitate that formed was filtered hot, washed with hot acetic acid, diethyl ether, and dried to give the desired nitroquinazoline 5a as light yellow solid (180 mg, rate 63.2%). m.p: 230.7–232.6 °C (227–229 °C, lit …”
Section: Methodsmentioning
confidence: 99%
“…By the procedure described above for 5a using 3 (218.21 mg, 1 m m ) and 3‐chloroaniline ( 4b , 127.57 mg, 1 m m ) to give 233 mg (77.7%) of yellow powder. m.p: 276.0–279.0 °C (278–281 °C, lit …”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…reported that the synthesis of ureido-4-quinolinamides, 22 showed antimalarial activity at MIC 0.25 mg/mL against chloroquine-sensitive Plasmodium falciparum strain [22]. Several 7-chloroquinolinyl thioureas, 23, 24 have been synthesized by Mahajan et al that possess excellent antimalarial properties [23].…”
Section: Biological Activity 31 Antimalarialmentioning
confidence: 99%
“…In this work, based on previous structure activity relationships (SARs) of sorafenib and its analogs we retained the diarylurea functionality as the key pharmacophore and focused our main modification on replacement of pyridyl carboxamid group of sorafenib with quinoxalindione moiety in order to investigate the impact of increasing rigidity at the end of this backbone on the biological activities of the resulting compounds. Since antibacterial activities of quinoxalindione and diaryl urea derivatives have been reported separately, we were interested in investigating the antimicrobial activities of these new hybrid compounds with both pharmacophore moieties in a single scaffold( 14 15 16 17 18 19 ).…”
Section: Introductionmentioning
confidence: 99%